276
Participants
Start Date
November 30, 2014
Primary Completion Date
November 30, 2016
Study Completion Date
October 5, 2017
DRL_RI
Two 1000 mg intravenous infusions, one each on Day 1 and Day 15
Rituxan
Two 1000 mg intravenous infusions, one each on Day 1 and Day 15
MabThera
Two 1000 mg intravenous infusions, one each on Day 1 and Day 15
Vinnytsia M.I. Pyrogov Regional Clinical Hospital, Vinnytsia
Medical Clinical Investigational Center MC LLC Health Clinic, Vinnytsia
M.V. Sklifosovskyi Poltava Regional Clinical Hospital, Poltava
Communal Healthcare Institution Kharkiv City Clinical Hospital #8, Kharkiv
Communal Institution Zaporzhzhia Regional Clinical Hospital of Zaporizhzhia Regional Council, Zaporizhzhia
Maulana Azad Medical College & Associated Lok Nayak Hospitals, New Delhi
lndraprastha Apollo Hospitals, New Delhi
Dayanand Medical College & Hosptial, Ludhiana
King George's Medical University, Lucknow
S. R. Kalla Memorial Gastro & General Hospital, Jaipur
Shri Nidaan Hospital & Hope Fertility Centre, Jaipur
Shalby Hospitals, Ahmedabad
Government Medical College & New Civil Hospital, Surat
Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai
Jehangir Clinical Development Centre Pvt. Ltd., Pune
Deennath Mangeshkar Hospital and Research Centre, Pune
Oyster & Pearl Hospital, Pune
lnamdar Multispeciality Hospital, Pune
Krishna Institute of Medical Sciences Ltd., Secunderabad
Yashoda Hospital, Secunderabad
Gurunank Care Hospital, Hyderabad
Care Hospitals, Hyderabad
Chanre Rheumatology & Immunology Center & Research, Bangalore
Jagadguru Sri Shivarathreeshwara Hospital, Mysore
Apollo Specialty Hosptials, Madurai
Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd, Hubli
State Institution National Scientific Center Acad. Strazhesko Institute of Cardiology of National Academy of Medical Science, Kyiv
State Institution D.F. Chebotariov Institute of Gerontology of NAMS of Ukraine, Kyiv
Lead Sponsor
Dr. Reddy's Laboratories Limited
INDUSTRY